CNNC (Cannonau) Current Deferred Revenue: $0.00 Mil (As of Mar. 2024)


What is Cannonau Current Deferred Revenue?

Cannonau CNNC Current Deferred Revenue is $0.00 Mil as of Mar. 2024.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Cannonau's current deferred revenue for the quarter that ended in Mar. 2024 was $0.00 Mil.

Cannonau Current Deferred Revenue Related Terms

Cannonau Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Cannonau's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannonau Current Deferred Revenue Chart

Cannonau Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cannonau Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
What does a Current Deferred Revenue of $0.00 Mil mean?
Cannonau (CNNC) has a Current Deferred Revenue of $0.00 Mil as of Mar. 2024. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Cannonau and its competitors.
Is Cannonau's Current Deferred Revenue too high?
Cannonau's current Current Deferred Revenue is $0.00 Mil.
How does Cannonau's Current Deferred Revenue compare to KOAN and THCT?
Cannonau's Current Deferred Revenue of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Drug Manufacturers company?
A good Current Deferred Revenue depends on the Drug Manufacturers industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Cannonau and its competitors. Cannonau's current Current Deferred Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannonau stock overvalued right now?
Cannonau (CNNC) has a current Current Deferred Revenue of $0.00 Mil. The current Current Deferred Revenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Cannonau (CNNC), the current Current Deferred Revenue is $0.00 Mil as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannonau Business Description

Address 937 Old Seneca Turnpike Road, Skaneateles, NY, USA, 13252-9318
Cannonau Corp is using cutting-edge nanotechnology plans to offer Cannabidiol (CBD) for improved bioavailability and maximum benefit. It believes that its formulas can be easily incorporated into a wide, offering customers an advantage when it counts.